(1)
Department of Family Medicine, University of California, Riverside, Riverside, CA, USA
Key Points
1.
Infectious complications in pregnancy include maternal or fetal morbidity, teratogenic or developmental abnormalities, and disruption of the course of pregnancy.
2.
Management of infection during pregnancy begins with thorough preconception evaluation.
3.
Routine screening of all prenatal patients for common asymptomatic infections is a cornerstone of prenatal care.
4.
Women should be screened by history for signs or symptoms that are suggestive of common infectious complications of pregnancy at each prenatal visit.
Background
Infection presents a particular challenge in pregnancy. Symptoms of infection may be subtle, unusual in presentation, or masked by other pregnancy-related symptoms. Infection may affect both the mother and fetus; antibiotic choices may be limited by concerns related to pregnancy and fetal development. As with most elements of obstetrical care, management of infection in pregnancy ideally begins in the preconception period. The preconception history can provide important data concerning infection risk such as recent exposures (toxoplasmosis, tuberculosis, cytomegalovirus), immunization status (influenza, measles, and varicella), and chronic infectious conditions (HIV, herpes, viral hepatitis). For some of these infections, appropriate preconception planning and risk reduction is the only effective intervention. A thorough physical examination may reveal evidence of such infections as active herpes, gonorrhea, or chlamydia. Preconception screening for HIV, tuberculosis, and syphilis, among other conditions, may allow for treatment prior to pregnancy, thereby decreasing the likelihood of adverse prenatal outcomes.
Infections occurring during the course of pregnancy may have two significant consequences. Direct maternal–fetal transmission may lead to infection not just in the mother but also in the fetus. Such infections may have very serious consequences for the fetus or newborn. Herpetic infection in newborns, for example, is associated with a 50 % mortality rate and significant morbidity among those infants who survive. In addition, some infectious agents are known to cause complications in the course of pregnancy, particularly preterm labor. Although most studies have shown conflicting data concerning the demonstrated benefit of diagnosis and treatment, most authorities recommend screening and treatment.
Symptoms of Infection in Pregnancy
Although diagnosis of infection in pregnancy is critically important, symptoms of infection in prenatal patients may be absent or difficult to detect or interpret. Many infectious etiologies are asymptomatic. Syphilis, latent-phase herpes, HIV, and others may be present without producing any symptoms in the pregnant patient. For these conditions, routine screening is recommended for all pregnant patients by history, physical examination, and/or diagnostic studies.
Some disease processes produce characteristic symptoms, which should be further evaluated whenever present. Such symptoms as fever, chills, bleeding per vagina, severe abdominal pain, or dysuria should lead to prompt evaluation. For other disease processes, the symptoms associated with infection may be difficult to interpret or may be masked by some of the common symptoms associated with pregnancy. Cervical mucus production may be increased during pregnancy and some women may interpret this increased mucus as infectious in cause. By contrast, some women may interpret an abnormal vaginal discharge as “normal” for pregnancy, delaying evaluation or failing to mention such symptoms during the course of prenatal care. Nonspecific abdominal pain is also a relatively common symptom occurring during pregnancy. Providers should be diligent in eliciting suggestive symptoms and should maintain a low threshold for following up such symptoms with appropriate diagnostic tests. As a general rule, women should be screened by history for symptoms that are suggestive of common infectious complications of pregnancy at each prenatal visit. Those patients who report such symptoms should be further evaluated for the possible presence of infection (Table 13.1).
Table 13.1
Antibiotics in pregnancy
Infection | Antibiotics |
---|---|
Gram positive | Penicillins |
First-generation cephalosporins | |
Clindamycin | |
Gram negative | Aminoglycosides (see text) |
Third-generation cephalosporins | |
Anaerobic | Clindamycin |
Special conditions | |
Urinary tract infection | Cephalosporins |
Nitrofurantoin | |
Ampicillin (see text) | |
Sulfisoxazole (see text) | |
Chlamydia | Erythromycin |
Azithromycin | |
Gonorrhea | Ceftriaxone |
Syphilis | Penicillin |
Yeast | Azole antifungal agents after the first trimester |
Bacterial vaginosis | Clindamycin |
Metronidazole after the first trimester | |
Trichomoniasis | Metronidazole after the first trimester |
Herpes | Acyclovir; cesarean section indicated if present at time of labor |
HIV | See Chap. 16 |
Group B strep | Ampicillin in labor |
Maternal Infection
The primary concern in pregnancy is with the health and welfare of the mother. Timely diagnosis and treatment of infection has direct health consequences for the mother and should be approached in the same manner as in nonpregnant patients. Routine prenatal care includes screening for gonorrhea, chlamydia, syphilis, HIV, hepatitis B, and urine culture for bacteriuria. These tests are performed in all patients regardless of symptoms. It is worth noting that most of these infections are sexually transmitted. Pregnancy can be taken as good evidence of unprotected sexual activity and therefore confers the infection risk associated with unprotected sex. Prenatal patients are also routinely screened for evidence of human papilloma virus through Pap smear screening. Although treatment is generally deferred until the patient is no longer pregnant, documentation of the presence and severity of dysplastic lesions is an important element of the comprehensive care plan. The timing and method of screening for these infectious conditions are reviewed in Chap. 3.
Patients with suggestive symptoms may also be screened for other infectious conditions. Patients with vaginal discharge should be evaluated for the presence of bacterial vaginosis and trichomoniasis in addition to gonorrhea and chlamydia. The presence of bacterial vaginosis has been associated with an increased risk of preterm contractions and preterm labor. Treatment of bacterial vaginosis or trichomoniasis is recommended after the first trimester. Patients with urinary symptoms such as dysuria or hematuria should be evaluated for possible urinary tract infection (UTI).